Texas A&M University researchers received NIH funding to expand organ-on-a-chip technology aimed at chemical safety testing. Led by Dr. Arum Han, the effort is part of a $15.3 million NIH-funded center focused on advancing organ-on-a-chip platforms. The program’s goal is to improve how chemicals are evaluated for safety—potentially cutting reliance on animal testing by generating more human-relevant data. For developers of next-gen toxicology tools and assay platforms, the award signals continued public investment in translational in vitro systems. The announcement ties engineering and biomedical translation directly to regulatory-relevant testing needs, with organ-on-a-chip models positioned as scalable alternatives where validated.